Applied DNA Sciences, Inc. (APDN)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 3.52M |
| Enterprise Value | 1.28M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.30 |
| Price/Book (mrq) | 0.83 |
| Enterprise Value/Revenue | 0.14 |
| Enterprise Value/EBITDA | -0.10 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.09 |
| 52-Week Change 3 | -79.75% |
| S&P500 52-Week Change 3 | 22.43% |
| 52 Week High 3 | 37.2000 |
| 52 Week Low 3 | 3.5900 |
| 50-Day Moving Average 3 | 8.5308 |
| 200-Day Moving Average 3 | 17.0507 |
Share Statistics
| Avg Vol (3 month) 3 | 12.98k |
| Avg Vol (10 day) 3 | 44.35k |
| Shares Outstanding 5 | 863.07k |
| Implied Shares Outstanding 6 | 979.56k |
| Float 8 | 682.66k |
| % Held by Insiders 1 | 12.12% |
| % Held by Institutions 1 | 26.03% |
| Shares Short (Apr 15, 2024) 4 | 14.93k |
| Short Ratio (Apr 15, 2024) 4 | 1.84 |
| Short % of Float (Apr 15, 2024) 4 | 2.19% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 1.76% |
| Shares Short (prior month Mar 15, 2024) 4 | 13.06k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | Nov 01, 2019 |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:20 |
| Last Split Date 3 | Apr 25, 2024 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Sept 30, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | -80.13% |
| Operating Margin (ttm) | -425.18% |
Management Effectiveness
| Return on Assets (ttm) | -55.96% |
| Return on Equity (ttm) | -110.02% |
Income Statement
| Revenue (ttm) | 9M |
| Revenue Per Share (ttm) | 13.56 |
| Quarterly Revenue Growth (yoy) | -83.10% |
| Gross Profit (ttm) | N/A |
| EBITDA | -12.2M |
| Net Income Avi to Common (ttm) | -7.29M |
| Diluted EPS (ttm) | -11.0000 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 3.36M |
| Total Cash Per Share (mrq) | 3.96 |
| Total Debt (mrq) | 1.12M |
| Total Debt/Equity (mrq) | 27.06% |
| Current Ratio (mrq) | 1.77 |
| Book Value Per Share (mrq) | 6.17 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -7.59M |
| Levered Free Cash Flow (ttm) | -4.02M |
© 2024 Yahoo. All rights reserved.